Literature DB >> 8034621

Purification of active herpes simplex virus-1 protease expressed in Escherichia coli.

P L Darke1, E Chen, D L Hall, M K Sardana, C A Veloski, R L LaFemina, J A Shafer, L C Kuo.   

Abstract

Assembly of viral capsids for replication of herpes simplex virus requires the proteolytic processing of the assembly protein ICP35. The protease responsible for this process is encoded within the 635-amino acid open reading frame of the UL26 gene of the virus. A simple purification scheme is given in this report for the native, mature form of the protease expressed in Escherichia coli. The scheme allows the preparation of milligram quantities of purified enzyme for elucidation of kinetic mechanism as well as for structural studies. Utilizing a 13-residue peptide substrate representing the natural cleavage site that releases the protease, kcat and Km values of the purified native enzyme are 2.0 min-1 and 0.88 mM, respectively. Thus, peptide cleavage is less efficient than reported for other viral proteases. The possibility exists that viral or cellular factors are involved in vivo for activation of the protease for herpes capsid maturation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034621

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

Authors:  R Zhang; J Durkin; W T Windsor; C McNemar; L Ramanathan; H V Le
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

3.  GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity.

Authors:  E Scarselli; A Urbani; A Sbardellati; L Tomei; R De Francesco; C Traboni
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Virus-specific interaction between the human cytomegalovirus major capsid protein and the C terminus of the assembly protein precursor.

Authors:  M Beaudet-Miller; R Zhang; J Durkin; W Gibson; A D Kwong; Z Hong
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Na, an autoproteolytic product of the herpes simplex virus type 1 protease, can functionally substitute for the assembly protein ICP35.

Authors:  B J Robertson; P J McCann; L Matusick-Kumar; V G Preston; M Gao
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Antibody cross-reactivity with CD46 and lack of cell surface expression suggest that moesin might not mediate measles virus binding.

Authors:  P Devaux; D Gerlier
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Cytomegalovirus protein substrates are not cleaved by the herpes simplex virus type 1 proteinase.

Authors:  A R Welch; E C Villarreal; W Gibson
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  Activity of purified hepatitis C virus protease NS3 on peptide substrates.

Authors:  C Steinkühler; A Urbani; L Tomei; G Biasiol; M Sardana; E Bianchi; A Pessi; R De Francesco
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo.

Authors:  H Aoki; T Akaike; K Abe; M Kuroda; S Arai; R Okamura; A Negi; H Maeda
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.